- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CCR5 and CXCR4 antagonist and agonist binding sites ; volume:3 ; number:1 ; day:21 ; month:12 ; year:2006 ; pages:1 ; date:12.2006
Retrovirology ; 3, Heft 1 (21.12.2006), 1, 12.2006
- Urheber
-
Teintze, Martin
- Beteiligte Personen und Organisationen
-
Wilkinson, Royce
Grieco, Paul
Mills, John
Dratz, Edward
SpringerLink (Online service)
- DOI
-
10.1186/1742-4690-3-S1-S39
- URN
-
urn:nbn:de:1111-2016080655710
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Teintze, Martin
- Wilkinson, Royce
- Grieco, Paul
- Mills, John
- Dratz, Edward
- SpringerLink (Online service)
Ähnliche Objekte (12)
CCR5 Antagonist and Agonist Binding Site Structures
Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection
Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
Discovery and characterization of an endogenous CXCR4 antagonist
Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists
Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
Chemokine receptors CXCR4 and CCR5: Cell surface expression, signaling and modulation by β-arrestin 2
Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy
Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses
Standing task difficulty related increase in agonist-agonist and agonist-antagonist common inputs are driven by corticospinal and subcortical inputs respectively
Macrocyclic polyamines inhibit HIV infection by interacting with the cellular HIV co-receptors CXCR4 and CCR5
Effekte chemisch induzierter β-Arrestin-1-Translokation an die Chemokinrezeptoren CXCR4 und CCR5
CCR5 Antagonist and Agonist Binding Site Structures
Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection
Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
Discovery and characterization of an endogenous CXCR4 antagonist
Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists
Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
Chemokine receptors CXCR4 and CCR5: Cell surface expression, signaling and modulation by β-arrestin 2
Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy
Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses
Standing task difficulty related increase in agonist-agonist and agonist-antagonist common inputs are driven by corticospinal and subcortical inputs respectively
Macrocyclic polyamines inhibit HIV infection by interacting with the cellular HIV co-receptors CXCR4 and CCR5
Effekte chemisch induzierter β-Arrestin-1-Translokation an die Chemokinrezeptoren CXCR4 und CCR5
CCR5 Antagonist and Agonist Binding Site Structures
Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection
Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
Discovery and characterization of an endogenous CXCR4 antagonist
Establishment of a novel CCR5 and CXCR4 expressing CD4+ cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists
Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
Chemokine receptors CXCR4 and CCR5: Cell surface expression, signaling and modulation by β-arrestin 2
Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy
Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses
Standing task difficulty related increase in agonist-agonist and agonist-antagonist common inputs are driven by corticospinal and subcortical inputs respectively
Macrocyclic polyamines inhibit HIV infection by interacting with the cellular HIV co-receptors CXCR4 and CCR5